~~<i id='E2FCF11CA1'><strike id='E2FCF11CA1'><tt id='E2FCF11CA1'><pre id='E2FCF11CA1'></pre></tt></strike></i>~~

Home» explore» explore

explore

author：hotspot 2025-09-30 21:48:37 Page View：43

Venture capitalist Alexis Borisy Vanessa Leroy for STAT

EQRx is done, sold for its cash.

The once-buzzy but now dormant biotech company is being acquired by Revolution Medicines, a developer of cancer drugs, the companies announced Tuesday.

The all-stock deal is essentially a balance-sheet transfer of $1 billion in cash from EQRx to Revolution. What was left of EQRx’s drug pipeline is being shelved.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： New Alzheimer's drugs heat up race for early detection blood tests
Next article： Bright Health sells Medicare Advantage business to Molina

focus

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

FILE-Abortion-rightsprotestersfillIndianaStatehousecorridorsandcheeroutsidelegislativechambers,Frida

Dems pitch expanding Medicare power to negotiate drug prices

Reps.RichardNeal(D-Mass.),Rep.FrankPallone(D-N.J.),andRep.JohnYarmuth(D-Ky.)JoeRaedle/GettyImagesWAS

Supreme Court strikes down use of affirmative action

ActivistsdemonstratedastheSupremeCourtheardoralargumentsonapairofaffirmativeactioncasesinOctober2022

New Alzheimer's drugs heat up race for early detection blood tests

MarionBerard/AFP/GettyImagesWiththeadventofdisease-modifyingAlzheimer’sdrugs,everyoneintheworldofAlz